Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cyclooxygenase-2 in human pathological disease.

Alane Koki¹, Nasir K Khan, B Mark Woerner

¹Searle/Monsanto Co., 700 Chesterfield Parkway N, St. Louis, MO 63017, USA.

Advances in Experimental Medicine and Biology

|April 1, 2003

Summary

Cyclooxygenase-2 (COX-2) is minimally present in normal human tissues but significantly upregulated in osteoarthritis, atherosclerosis, and cancer. COX-2 inhibition may offer therapeutic benefits for these inflammatory diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Functional Consequences of Long COVID Need to Be Addressed by Occupational Therapists.

The American journal of occupational therapy : official publication of the American Occupational Therapy Association·2024

Same author

Creating a Comprehensive Pandemic Response to Decrease Hospitalist Burnout During COVID-19: Intervention vs Control Results in 2 Comparable Hospitals (HOSP-CPR).

Journal of general internal medicine·2023

Same author

Biology and postnatal development of organ systems of cynomolgus monkeys (Macaca fascicularis).

Journal of medical primatology·2022

Same author

Age- and sex-related changes in body weights and clinical pathology analytes in cynomolgus monkeys (Macaca Fascicularis) of Mauritius origin.

Veterinary clinical pathology·2022

Same author

SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet.

American journal of physiology. Heart and circulatory physiology·2022

Same author

Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease.

British journal of pharmacology·2021

Area of Science:

Biomedical research
Molecular biology
Pathology

Background:

Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, play critical roles in cellular processes.
Understanding the differential expression of COX isoforms is crucial for developing targeted therapies.

Purpose of the Study:

To characterize the expression patterns of COX-1 and COX-2 in normal human tissues and in inflammatory conditions such as osteoarthritis, atherosclerosis, and cancer.
To investigate the potential therapeutic implications of targeting COX-2.

Main Methods:

Immunohistochemistry was used to analyze COX expression in tissue biopsies.
Western blot and quantitative RT-PCR were employed for further validation and quantification.
Tissues examined included those from osteoarthritis, atherosclerosis, cancer, and various normal human organs.

Related Experiment Videos

Main Results:

COX-2 was largely absent in normal adult tissues, with low-level constitutive expression in specific epithelia and certain brain regions.
COX-2 expression was markedly induced in osteoarthritis (synovium, osteophytes), atherosclerosis (macrophages, endothelium), and epithelial cancers (inflammatory cells, neoplastic lesions, vasculature).
COX-1 expression was ubiquitous across both normal and pathological conditions.

Conclusions:

The distinct upregulation of COX-2 in inflammatory diseases suggests its significant role in their pathogenesis.
COX-2 inhibitors show promise for the prevention and treatment of osteoarthritis, cardiovascular diseases, and epithelial cancers.